Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
Go back to Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026| (NASDAQ: DFTX) | Delayed: 39.28 +0.47 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.81 | 52 Week High | $ | |||
| Open | $39.00 | 52 Week Low | $ | |||
| Day High | $39.54 | P/E | N/A | |||
| Day Low | $37.97 | EPS | $ | |||
| Volume | 2,037,992 | |||||
